This company listing is no longer active
DSM N Stock Overview
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
DSM-Firmenich AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €2,194.20 |
52 Week High | €2,891.06 |
52 Week Low | €2,194.20 |
Beta | 0.72 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | -25.43% |
33 Year Change | n/a |
5 Year Change | 11.50% |
Change since IPO | 11.50% |
Recent News & Updates
Recent updates
Shareholder Returns
DSM N | MX Chemicals | MX Market | |
---|---|---|---|
7D | 0% | 0.3% | -0.5% |
1Y | -25.4% | -19.3% | 6.4% |
Return vs Industry: DSM N exceeded the MX Chemicals industry which returned -28.8% over the past year.
Return vs Market: DSM N underperformed the MX Market which returned 3.2% over the past year.
Price Volatility
DSM N volatility | |
---|---|
DSM N Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 4.2% |
Market Average Movement | 4.1% |
10% most volatile stocks in MX Market | 6.0% |
10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: DSM N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DSM N's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1902 | 19,973 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG, a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants.
DSM-Firmenich AG Fundamentals Summary
DSM N fundamental statistics | |
---|---|
Market cap | Mex$14.40b |
Earnings (TTM) | Mex$8.56b |
Revenue (TTM) | Mex$158.15b |
1.7x
P/E Ratio0.1x
P/S RatioIs DSM N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DSM N income statement (TTM) | |
---|---|
Revenue | €8.39b |
Cost of Revenue | €5.70b |
Gross Profit | €2.69b |
Other Expenses | €2.24b |
Earnings | €454.00m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 02, 2023
Earnings per share (EPS) | 67.80 |
Gross Margin | 32.06% |
Net Profit Margin | 5.41% |
Debt/Equity Ratio | 26.6% |
How did DSM N perform over the long term?
See historical performance and comparison